Finland· FI-REL-REL63198
Cluvot
A coagulation factor xiii product containing factor xiii (fibrin stabilising factor), registered in Finland by Abacus Medicine A/S. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Coagulation factor xiii is registered in 9 of 19 countries.
Countries holding a registration under ATC B02BD07 (coagulation factor xiii), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Coagulation factor xiii · ATC B02BD07
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Factor XIII (fibrin stabilising factor)
- Manufacturer
- Abacus Medicine A/S
- Country
- Finland (FI)
- ATC code
- B02BD07
- ATC class
- Coagulation factor XIII
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa5317991250 IUEUR 2403.39
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for coagulation factor xiii.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor xiii · interactions on record
2 records
- 2 severe
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Coagulation factor xiii in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCLUVOT 1250 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSIONCsl Behring Gmbh
- United KingdomFibrogammin 1,250unit powder and solvent for solution for injection vialsCSL Behring UK Ltd
- CanadaCORIFACT 1250CSL BEHRING CANADA INC
- SwitzerlandFibrogammin 1'250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungCSL Behring AG
- NetherlandsCluvot 1250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusieCSL Behring GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecc9cdc5-1224-4ed4-abe6-66ef3de83bf2 GET /v1/drugs/ecc9cdc5-1224-4ed4-abe6-66ef3de83bf2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektio-/infuusiokuiva-aine ja liuotin, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "1250 IU",
"atc_label": "hyytymistekijä XIII",
"ma_number": "44137",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL63198",
"authorised_at": "2025-01-27"
}See everything about coagulation factor xiii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.